Illinois doctors renewing their medical licenses will soon be able to satisfy part of a longstanding training requirement by studying something many of them were never taught in depth: menopause. Governor JB Pritzker signed Senate Bill 3325 into law on Friday, allowing licensed healthcare professionals to count continuing education coursework in perimenopause and menopause toward their mandatory implicit bias awareness training, starting January 1, 2027.
The change, first reported by NBC 5 Chicago, doesn't add new hours to providers' existing continuing education load. Instead, according to WAND TV, it lets menopause-specific coursework fulfill a requirement Illinois healthcare professionals already have to complete periodically to keep their licenses active. Pritzker signed the bill alongside House Bill 5284, known as the Illinois Menopause Equity and Care Act, which mandates that all private group and individual health insurance plans in the state cover medically necessary evaluations and treatments for perimenopause and menopause starting January 1, 2028. Covered treatments under that law include FDA-approved hormonal and non-hormonal therapies as well as treatments for menopause-related osteoporosis, per the same outlet's report.
New Workplace Protections Take Effect First
HB 5284 also amends the Illinois Human Rights Act to prohibit employment discrimination based on menopause-related conditions, effective January 1, 2027. The law requires employers with four or more workers to provide reasonable accommodations such as flexible scheduling and climate-adjusted workspaces, according to a guide from FordHarrison. Menopause-related conditions covered under the act include vasomotor symptoms, sleep disruption, cognitive changes, and joint pain.
With HB 5284 on the books, Illinois joins Rhode Island as one of only two states in the nation to explicitly protect employees experiencing menopause-related conditions under state workplace anti-discrimination law, FordHarrison notes. Similar bills have been introduced in California, New York, and New Jersey, but have not yet become law. The act also requires the Illinois Department of Public Health to develop and distribute online educational resources covering symptoms, evidence-based therapies, and patient rights, and it establishes an annual state Menopause Awareness Week.
A Workforce Shortage Behind the Push
The legislative push traces back to stark findings in Illinois Senate Joint Resolution 52, which documented fewer than 100 certified menopause health professionals statewide despite women making up 51% of Illinois' population, according to state legislative records cataloged by LegiScan. Later 2026 state estimates put the number closer to 200 certified specialists, still a fraction of what advocates say is needed. The same resolution found that 94% of Illinois women reported feeling inadequately informed about menopause, that 70% of those who sought medical care for symptoms did not receive treatment, and that only 19% of women aged 40 to 60 received an official diagnosis, even though menopausal symptoms often persist for two to ten years.
The economic case for reform has national roots as well. A 2023 study from the Mayo Clinic, which surveyed more than 4,400 employed midlife women across the country, found that untreated menopausal symptoms cost U.S. workers an estimated $1.8 billion annually in lost productivity, and up to $26.6 billion per year when direct medical expenses are factored in. Research from the National Health Law Program adds a coverage-gap dimension: Medicaid enrollees nationally are 47% more likely to go without menopause treatment than privately insured individuals due to prior authorization hurdles and gaps in coverage for specialized therapies, a disparity that disproportionately affects low-income and minority women.
Building on Earlier Insurance Mandates
Friday's signing builds on a 2024 law, HB 5295, which already required state-regulated private insurance and Medicaid managed care plans to cover medically necessary hormonal and non-hormonal menopause treatments across all FDA-approved administration methods starting January 1, 2026. That measure, detailed by McDermott Will & Schulte, was originally introduced in February 2024 to address financial barriers to care. Taken together, the 2024, 2026, and 2028 timelines show a state government trying to close both financial and educational gaps in menopause care on parallel tracks rather than all at once.
Hoodline reported on sweeping 2026 mandates tied to this broader healthcare push in December, and the issue has drawn national attention to Illinois before: Jill Biden and Halle Berry visited Chicago in January 2024 to advocate for expanded menopause research at the University of Illinois Chicago. Open questions remain about how quickly medical training providers will roll out approved menopause coursework, how small and mid-sized employers will adapt to the new accommodation requirements, and whether insurer compliance will translate into lower out-of-pocket costs for patients once the coverage mandate takes effect in 2028.
